Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Comparative, Randomized Controlled Clinical Trial to Evaluate the Performance and the Safety of Promelaxin® Micro-enemas Vs. Macrogol 4000 Per os in the Treatment of Functional Chronic Constipation in Children Aged Between 6 and 48 Months.

NCT02751411 is registered in ClinicalTrials.gov with Aboca Spa Societa' Agricola as lead sponsor.

NCT NCT02751411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02751411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Comparative, Randomized Controlled Clinical Trial to Evaluate the Performance and the Safety of Promelaxin® Micro-enemas Vs. Macrogol 4000 Per os in the Treatment of Functional Chronic Constipation in Children Aged Between 6 and 48 Months.
Lead sponsor
Aboca Spa Societa' Agricola
Phase
Phase 4
Overall status
Completed
Start date
April 18, 2016
Completion date
March 17, 2020
Enrollment
158 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic functional constipation